Role of the A2Breceptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats

L. Antonioli, M. Fornai, O. Awwad, G. Giustarini, C. Pellegrini, M. Tuccori, V. Caputi, M. Qesari, I. Castagliuolo, P. Brun, M.C. Giron, C. Scarpignato, C. Blandizzi, R. Colucci

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background and Purpose: Adenosine A2Breceptors regulate several physiological enteric functions. However, their role in the pathophysiology of intestinal dysmotility associated with inflammation has not been elucidated. Hence, we investigated the expression of A2Breceptors in rat colon and their role in the control of cholinergic motility in the presence of bowel inflammation. Experimental Approach: Colitis was induced by 2,4- dinitrobenzenesulfonic acid (DNBS). Colonic A2Breceptor expression and localization were examined by RT-PCR and immunofluorescence. The interaction between A2Breceptors and adenosine deaminase was assayed by immunoprecipitation. The role of A2Breceptors in the control of colonic motility was examined in functional experiments on longitudinal muscle preparations (LMPs). Key Results: A2Breceptor mRNA was present in colon from both normal and DNBS-treated rats but levels were increased in the latter. A2Breceptors were predominantly located in the neuromuscular layer, but, in the presence of colitis, were increased mainly in longitudinal muscle. Functionally, the A2Breceptor antagonist MRS 1754 enhanced both electrically-evoked and carbachol-induced cholinergic contractions in normal LMPs, but was less effective in inflamed tissues. The A2Breceptor agonist NECA decreased colonic cholinergic motility, with increased efficacy in inflamed LMP. Immunoprecipitation and functional tests revealed a link between A2Breceptors and adenosine deaminase, which colocalize in the neuromuscular compartment. Conclusions and Implications: Under normal conditions, endogenous adenosine modulates colonic motility via A2Breceptors located in the neuromuscular compartment. In the presence of colitis, this inhibitory control is impaired due to a link between A2Breceptors and adenosine deaminase, which catabolizes adenosine, thus preventing A2Breceptor activation. © 2013 The British Pharmacological Society.
Original languageEnglish
Pages (from-to)1314-1329
Number of pages16
JournalBritish Journal of Pharmacology
Volume171
Issue number5
DOIs
Publication statusPublished - 1 Mar 2014
Externally publishedYes

Keywords

  • A2Breceptor
  • adenosine
  • colitis
  • colonic neuromuscular contractions
  • adenosine 5' (n ethylcarboxamide)
  • adenosine A2b receptor
  • adenosine deaminase
  • carbachol
  • dinitrobenzenesulfonic acid
  • messenger RNA
  • n (4 cyanophenyl) 2 [4 (2,3,6,7 tetrahydro 2,6 dioxo 1,3 dipropyl 1h purin 8 yl)phenoxy]acetamide
  • sulfonic acid derivative
  • unclassified drug
  • animal experiment
  • animal model
  • animal tissue
  • article
  • cholinergic activity
  • controlled study
  • disease association
  • immunofluorescence
  • immunoprecipitation
  • intestinal dysmotility
  • male
  • neuromuscular function
  • nonhuman
  • priority journal
  • protein determination
  • protein expression
  • protein function
  • protein localization
  • protein protein interaction
  • rat
  • reverse transcription polymerase chain reaction

Fingerprint

Dive into the research topics of 'Role of the A2Breceptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats'. Together they form a unique fingerprint.

Cite this